Nathalie Scholler

Cutting edge: CD83 regulates the development of cellular immunity.

Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.

Bead-based ELISA for validation of ovarian cancer early detection markers.

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.

Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.

A mouse to human search for plasma proteome changes associated with pancreatic tumor development.

Systematic evaluation of candidate blood markers for detecting ovarian cancer.

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Maternal mortality from systemic illness: unraveling the contribution of the immune response.

Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.

Use of high density antibody arrays to validate and discover cancer serum biomarkers.

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

CA125 in ovarian cancer.

Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Novel surface targets and serum biomarkers from the ovarian cancer vasculature.

Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor.

Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.

Oncology biomarkers for gynecologic malignancies.

A universal strategy for adoptive immunotherapy of cancer through use of a novel T cell antigen receptor.